difference between phentermine and glp 1 vs. Ozempic for Weight Loss: 8 Differences to Know GLP 1 drugs for weight

Robust, randomised, placebo-controlled human trials are essentially absent for both peptides

MacDonald PE, Rorsman P (2023) Metabolic messengers: glucagon

Obesity, insulin resistance, and type 2 diabetes are all known to increase the risk of dementia, largely due to their role in driving inflammation, vascular damage, and other long-term stressors on the brain

The body needs time to adapt to simultaneous GLP-1, GIP, and glucagon modulation

Cancer history: Growth factor-modulating peptides like Dihexa may warrant avoidance in those with cancer history, though evidence for concern remains theoretical

Frequently Asked Questions 1 2 3 PROST BIOTECH SDN BHD Evidence-based educational resources for metabolic health and cellular optimization